Astellas Pharma Europe is part of Astellas Pharma Inc. which is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally.
A young and forward-thinking company, Astellas is dedicated to improving the lives of people around the world through providing innovative and reliable pharmaceutical products.
Formed in 2005 through the merger of Yamanouchi and Fujisawa, Astellas continues to remain committed to developing first-in-class and best-in-class products in key therapeutic areas by combining outstanding R&D with marketing capabilities and continuing growth in the world pharmaceutical market.
In October 2006, Astellas launched its management strategy, VISION 2015. Our declared aim is to become a global category leader (GCL) in a number of therapeutic areas in which further innovation can fulfil unmet patient needs. Integral to this vision is CHANGING TOMORROW™, a wide-reaching campaign launched in 2008, which expresses the company’s potential for creating a brighter future for all its stakeholders, above all for patients.
With significant ongoing investment in R&D, Astellas continues to strengthen its capabilities as a research-driven pharmaceutical company, bringing effective therapies to patients around the world and continuing to build trusted networks amongst physicians and partners.
In Europe, Astellas’ key strengths lie in the therapy areas of Transplantation, Urology and Anti-Infectives and Pain Management. In addition, Astellas is committed to developing a portfolio of treatments to fulfil unmet needs in Oncology.
Astellas Pharma Europe Ltd. is headquartered just outside London in Chertsey and has 21 Sales Affiliates across Europe, CIS states and South Africa. Through Astellas Pharma International, its licensees, and distributors, the company is also responsible for sales throughout the Middle East and Africa.
Astellas Pharma Europe employs nearly 3,800 staff. In addition to its 21 Sales Affiliates, the company has 14 Promotional Offices, 3 Manufacturing plants and 1 Research & Development (R&D) centre in Europe. Astellas Pharma Europe is committed to expanding its operations in this important and growing region.
Please view Astellas Global Code of Conduct here: www.astellas.com/en/corporate/standard/
Please view Astellas Global Policy Summary / Position Statements here: www.astellas.com/en/corporate/comp_policy/